NCT02869724Unknown不适用
Divided Drug Delivery : a Way to Prevent Repeated Volutary Drug Intoxications.
University Hospital, Grenoble2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2014年3月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Evaluate the efficacy of an advice with a weekly divided drug delivery, compared to an usual monthly delivery in the prevention of voluntary drug intoxications repeated
研究概览
简要总结
This study will evaluate the efficacy of an advice with a weekly divided drug delivery, compared to an usual monthly delivery in the prevention of voluntary drug intoxications repeated.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Men and women between 18 and 65 years.
- •Hospitalized after a voluntary drug intoxication.
- •History of two voluntary drug intoxications at least.
- •Person registered for social security.
- •Signed free consent.
排除标准
- •Patients under treatment for opiate split
- •Acute or chronicgoing wild.
- •Cognitive problems hindering understanding of questionnaires
- •Persons targeted by articles L1121-5 to L1121-8 of CSP
结局指标
主要结局
Evaluate the efficacy of an advice with a weekly divided drug delivery, compared to an usual monthly delivery in the prevention of voluntary drug intoxications repeated
时间窗: 6 months
Number of cumulative voluntary drug intoxications throughout the 6 months
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Barriers and Breakthroughs in IMPlementing Split Regimen OVEr Single DoseColonoscopy: Bowel PreparationNCT03581175S. Andrea Hospital8,267
已完成
2 期
Safety and Efficacy Study of ABX-EGF in Patients With Renal Cancer, Part 2Advanced Renal Cell CarcinomaNCT00425035Amgen115
已完成
不适用
CYP3A4 phenotype-based dosing of irinotecaCancerISRCTN84131514Erasmus Medical Centre (Netherlands)40
已完成
1 期
A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148)Postoperative Nausea and VomitingNCT00819039Merck Sharp & Dohme LLC98
终止
2 期
Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast CancerNeoplasmsNCT00979641Tampere University Hospital65